wr 1065 has been researched along with Experimental Mammary Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachy, CM; Cassatt, DR; Fazenbaker, CA; Kifle, G; McCarthy, MP | 1 |
1 other study(ies) available for wr 1065 and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure.
Topics: Amifostine; Animals; Dose Fractionation, Radiation; Drug Evaluation, Preclinical; Female; Injections, Intravenous; Injections, Subcutaneous; Mammary Neoplasms, Experimental; Mercaptoethylamines; Mouth Mucosa; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Stomatitis; Tissue Distribution | 2005 |